News

Exxon Mobil Corporation (XOM) Q3 2025 Earnings Call Transcript

1 Mins read

Q3: 2025-10-31 Earnings Summary

EPS of $1.88 beats by $0.05

 | Revenue of $85.29B (-5.25% Y/Y) beats by $1.69B

Exxon Mobil Corporation (XOM) Q3 2025 Earnings Call October 31, 2025 9:30 AM EDT

Company Participants

James Chapman – VP of Investor Relations & Treasurer
Darren Woods – Chairman of the Board, President & CEO
Kathryn Mikells – Senior VP & CFO

Conference Call Participants

Neil Mehta – Goldman Sachs Group, Inc., Research Division
Devin McDermott – Morgan Stanley, Research Division
Arun Jayaram – JPMorgan Chase & Co, Research Division
Douglas George Blyth Leggate – Wolfe Research, LLC
Bob Brackett – Sanford C. Bernstein & Co., LLC., Research Division
Sam Margolin – Wells Fargo Securities, LLC, Research Division
Paul Cheng – Scotiabank Global Banking and Markets, Research Division
Biraj Borkhataria – RBC Capital Markets, Research Division
Ryan Todd – Piper Sandler & Co., Research Division
Wei Jiang – Barclays Bank PLC, Research Division
Jean Ann Salisbury – BofA Securities, Research Division
Jason Gabelman – TD Cowen, Research Division
Paul Sankey – Sankey Research LLC
Phillip Jungwirth – BMO Capital Markets Equity Research

Presentation

James Chapman
VP of Investor Relations & Treasurer

Good morning, everyone. Welcome to ExxonMobil’s Third Quarter 2025 Earnings Call. Today’s call is being recorded. We appreciate you joining us. I’m Jim Chapman, Vice President, Treasurer and Investor Relations. And I’m joined by Darren Woods, Chairman and Chief Executive Officer; and Kathy Mikells, Senior Vice President and Chief Financial Officer.

This quarter’s presentation and prerecorded remarks are available on the Investors section of our website. They are meant to accompany the third quarter earnings press release, which is posted in the same location. During today’s presentation, we’ll make forward-looking remarks, including comments on our long-term plans, which are subject to risks and uncertainties.

Please read our cautionary statement on Slide 2. You can find more information on the risks and uncertainties that apply to any forward-looking statements in our SEC filings on our website. We also provide supplemental information at the end of our

Read the full article here

Related posts
News

HTD: Tax-Advantaged Monthly Income From Dividends (NYSE:HTD)

1 Mins read
This article was written by Follow David A. Johnson is founder and principal of Endurance Capital Management, a New Jersey Limited Liability…
News

Jasper Therapeutics, Inc. (JSPR) Discusses Investigation Into BEACON Study Anomalies and Preliminary ETESIAN Asthma Data - Slideshow (NASDAQ:JSPR) 2025-12-04

1 Mins read
This article was written by Follow Seeking Alpha’s transcripts team is responsible for the development of all of our transcript-related projects. We…
News

Qiagen N.V. (QGEN) Presents at Evercore 8th Annual Healthcare Conference Transcript

1 Mins read
Follow Play Earnings CallPlay Earnings Call Qiagen N.V. (QGEN) Evercore 8th Annual Healthcare Conference December 3, 2025 10:50 AM EST Company Participants…
Get The Latest News

Subscribe to get the top fintech and
finance news and updates.

Leave a Reply

Your email address will not be published. Required fields are marked *